133 Argatroban Use in Therapeutic Plasma Exchange (TPE): A Case of Dynamic Anticoagulation Response
Saved in:
| Main Authors: | Jennifer E. Stanton, Alexander R. Nixon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037925001037 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognosis of Severe Covid-19 patients after treatment with Therapeutic Plasma Exchange (TPE)
by: Maliha Khalid, et al.
Published: (2022-12-01) -
WCN25-2435 THERAPEUTIC PLASMA EXCHANGE (TPE) IN THE TREATMENT OF RENAL DISEASES: A SINGLE CENTER EXPERIENCE
by: UTPAL KALITA, et al.
Published: (2025-02-01) -
WCN24-1892 THERAPEUTIC PLASMA EXCHANGE WITH TPE 2000 MEMBRANE FOR ANTIBODY-MEDIATED CARDIAC TRANSPLANT REJECTION CASE REPORT
by: Lilia María Rizo Topete, et al.
Published: (2024-04-01) -
Anticoagulant regimens for different therapeutic plasma exchange modes
by: Ruishan Yao, et al.
Published: (2025-06-01) -
Argatroban for Anticoagulation in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019
by: Lauren A. Sattler, MD, et al.
Published: (2021-09-01)